STACY SIMONS: Open Payments
NPI 1952844185 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,279 in 96 payments from 21 companies in 2025. Trend: 2023 $469 · 2024 $1,110 · 2025 $2,279
Food & beverage: $2,177Education: $102
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $645 |
| Teva Pharmaceuticals USA, Inc. | 16 | $271 |
| Neurocrine BioSciences, Inc. | 11 | $235 |
| UCB, Inc. | 9 | $196 |
| SK Life Science, Inc. | 6 | $174 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| Medtronic, Inc. | 1 | $102 |
| Lilly USA, LLC | 5 | $91 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Genentech USA, Inc. | 2 | $52 |
Products named: QULIPTA, AUSTEDO XR, INGREZZA, UBRELVY, Zilbrysq, REXULTI, PERCEPT PC BRAINSENSE, KISUNLA.
Industry payments across CA — which companies pay providers there.
